Hezong Medicine Easy-To-Buy Pharmaceutical
300937----
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Hezong Medicine Easy-To-Buy Pharmaceutical(300937) the Revenue is 1.114 B (-2.08%);the EBIT is 4.893 M (-50.35%);the EPS is -0.0323 (-173.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.11B2.08%
----
----
EBIT
0.00B50.35%
----
----
EPS
-0.0323173.91%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf